Physician profile
Arshish Dua
NPI 1710372321
$4,650.25
in general payments reported to CMS, 2019-2025
11 companies · $482 in 2025
The $482 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2021: $1,091 · 2022: $769 · 2023: $1,773 · 2024: $137 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,693 · Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,693.42 |
| Food and Beverage | $698.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,605.01 | 2019-2025 | Orise, Axios, Resolution 360 Clip |
| Ovesco Endoscopy USA, INC. | $697.12 | 2023 | |
| Apollo Endosurgery US INC | $323.39 | 2022 | |
| Conmed Corporation | $210.62 | 2022-2024 | Conmed Biliary |
| Madrigal Pharmaceuticals | $203.16 | 2025 | Rezdiffra |
| Abbvie INC. | $161.68 | 2019 | |
| Abbott Laboratories | $158.55 | 2022 | |
| Gilead Sciences, INC. | $99.67 | 2024-2025 | |
| Erbe USA INC | $75.00 | 2019 | |
| Olympus America INC. | $69.62 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.43 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arshish Dua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.